Chapter 43. Selection of Peritoneal Dialysis as Renal Replacement Therapy

  1. Donald A. Molony MD4,5 and
  2. Jonathan C. Craig MD, PhD6,7
  1. Norbert Lameire MD1,
  2. Raymond Vanholder MD Associate Head of the Nephrology1,2,3 and
  3. Wim Van Biesen MD1

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch43

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Lameire, N., Vanholder, R. and Van Biesen, W. (2008) Selection of Peritoneal Dialysis as Renal Replacement Therapy, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch43

Editor Information

  1. 4

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 5

    Houston Medical School, Houston, Texas, USA

  3. 6

    School of Public Health, University of Sydney, Australia

  4. 7

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. 1

    Renal Division, Department of Internal Medicine, University Hospital Ghent, Ghent, Belgium

  2. 2

    University of Ghent, Belgium

  3. 3

    Division of the Ghent University Hospital, Ghent, Belgium

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • Chronic Kidney Disease Stage 5 - peritoneal dialysis (PD);
  • peritoneal dialysis as renal replacement therapy;
  • factors driving modality selection;
  • PD in special patient groups;
  • quality of life and socio-economical considerations;
  • PD before transplantation and in failed transplant patients;
  • US Renal Data System (USRDS)


This chapter contains sections titled:

  • Introduction

  • Factors driving modality selection

  • PD in special patient groups

  • References